» Articles » PMID: 37424811

LncRNA ASBEL and LncRNA Erbb4-IR Reduce Chemoresistance Against Gemcitabine and Cisplatin in Stage IV Lung Squamous Cell Carcinoma Via the MicroRNA-21/LZTFL1 Axis

Overview
Journal Am J Cancer Res
Specialty Oncology
Date 2023 Jul 10
PMID 37424811
Authors
Affiliations
Soon will be listed here.
Abstract

Drug resistance is a major cause of treatment failure and post-treatment disease progression in patients with cancer. This study aimed to investigate the mechanisms of chemoresistance to gemcitabine (GEM) plus cisplatin (cis-diamminedichloroplatinum, DDP) combination therapy in stage IV lung squamous cell carcinoma (LSCC). It also examined the functional role of lncRNA ASBEL and lncRNA Erbb4-IR in the malignant progression of LSCC. The expression of lncRNA ASBEL, lncRNA Erbb4-IR, miR-21, and LZTFL1 mRNA was examined in human stage IV LSCC tissues and adjacent normal tissues, human LSCC cells and normal human bronchial epithelial cells using qRT-PCR. Furthermore, LZTFL1 protein levels were also examined using western blots. Cell proliferation, cell migration and invasion, and cell cycle progression and apoptosis were evaluated using the CCK-8, transwell, and flow cytometry assays, respectively. Based on the treatment response, LSCC tissues were classified as GEM-, DDP-, and GEM+DDP-sensitive/resistant. The MTT assay was performed to assess the chemoresistance of human LSCC cells to GEM, DDP, and GEM+DDP following transfection experiments. The results showed that lncRNA ASBEL, lncRNA Erbb4-IR, and LZTFL1 were down-regulated in human LSCC tissues and cells, whereas miR-21 was up-regulated. In stage IV human LSCC tissues, miR-21 levels were negatively correlated with those of lncRNA ASBEL, lncRNA Erbb4-IR, and LZTFL1 mRNA. The overexpression of lncRNA ASBEL and lncRNA Erbb4-IR inhibited cell proliferation, migration, and invasion. It also blocked cell cycle entry and accelerated apoptosis. These effects were mediated by the miR-21/LZTFL1 axis and reduced chemoresistance to GEM+DDP combination therapy in stage IV human LSCC. These findings indicate that lncRNA ASBEL and lncRNA Erbb4-IR function as tumor suppressors in stage IV LSCC and attenuate chemoresistance to GEM+DDP combination therapy via the miR-21/LZTFL1 axis. Hence, lncRNA ASBEL, lncRNA Erbb4-IR, and LZTFL1 may be targeted to enhance the efficacy of GEM+DDP combination chemotherapy against LSCC.

Citing Articles

Non-coding RNAs and exosomal non-coding RNAs in lung cancer: insights into their functions.

Lv X, Yang L, Xie Y, Momeni M Front Cell Dev Biol. 2024; 12:1397788.

PMID: 38859962 PMC: 11163066. DOI: 10.3389/fcell.2024.1397788.


Advances in applications of artificial intelligence algorithms for cancer-related miRNA research.

Lu H, Zhang J, Cao Y, Wu S, Wei Y, Yin R Zhejiang Da Xue Xue Bao Yi Xue Ban. 2024; 53(2):231-243.

PMID: 38650448 PMC: 11057993. DOI: 10.3724/zdxbyxb-2023-0511.

References
1.
Afzali M, Vatankhah M, Ostad S . Investigation of simvastatin-induced apoptosis and cell cycle arrest in cancer stem cells of MCF-7. J Cancer Res Ther. 2016; 12(2):725-30. DOI: 10.4103/0973-1482.146127. View

2.
Li S, Li J, Yu Z . Tumor suppressive functions of LZTFL1 in hepatocellular carcinoma. Onco Targets Ther. 2019; 12:5537-5544. PMC: 6628092. DOI: 10.2147/OTT.S196925. View

3.
Kunita A, Morita S, Irisa T, Goto A, Niki T, Takai D . MicroRNA-21 in cancer-associated fibroblasts supports lung adenocarcinoma progression. Sci Rep. 2018; 8(1):8838. PMC: 5995955. DOI: 10.1038/s41598-018-27128-3. View

4.
Chen M, Zhong L, Yao S, Zhao Y, Liu L, Li L . Verteporfin Inhibits Cell Proliferation and Induces Apoptosis in Human Leukemia NB4 Cells without Light Activation. Int J Med Sci. 2017; 14(10):1031-1039. PMC: 5599928. DOI: 10.7150/ijms.19682. View

5.
Liu Z, Dang C, Xing E, Zhao M, Shi L, Sun J . Overexpression of Improves Cisplatin Sensitivity in Hepatocellular Carcinoma Through Sponging . DNA Cell Biol. 2019; 38(11):1366-1373. DOI: 10.1089/dna.2019.4882. View